PARAMETRIC PORTFOLIO ASSOCIATES LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$82,000
-3.5%
78,456
+173.0%
0.00%
Q4 2015$85,000
-4.5%
28,740
+2.5%
0.00%
Q3 2015$89,000
-36.9%
28,040
+17.7%
0.00%
Q2 2015$141,000
-66.5%
23,832
-39.4%
0.00%
-100.0%
Q1 2015$421,000
+82.3%
39,352
+59.9%
0.00%
Q4 2014$231,000
+16.1%
24,611
-4.9%
0.00%
Q3 2014$199,000
-25.5%
25,885
-13.0%
0.00%
-100.0%
Q2 2014$267,000
+86.7%
29,740
+11.1%
0.00%
Q1 2014$143,00026,7800.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2016
NameSharesValueWeighting ↓
Aisling Capital LLC 2,010,000$905,0000.21%
GLOBEFLEX CAPITAL L P 226,959$102,0000.03%
ACUTA CAPITAL PARTNERS, LLC 62,800$28,0000.01%
MENTA CAPITAL LLC 195,136$87,0000.01%
Orbimed Advisors 1,073,000$481,0000.01%
GOODWIN DANIEL L 22,679$10,0000.00%
TUDOR INVESTMENT CORP ET AL 215,800$97,0000.00%
Renaissance Technologies 2,214,396$992,0000.00%
STOCK YARDS BANK & TRUST CO 30,170$14,0000.00%
HIGHLAND CAPITAL MANAGEMENT, LLC 41,000$18,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders